A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...

Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

ALS took many things from columnist Juliet Taylor's late husband, Jeff, including the end of his career, which was ...

With the hold lifted, Amylyx can begin screening and enrolling for its Phase 1 LUMINA trial, which will test AMX0114 in ALS ...

A study in Italy found ALS incidence and onset rose with living near arable crops (cereals, beans, root crops), and with ...

The ALS Association will host its second ALS Nexus conference in August, with the goal of making the disease a livable one ...

Columnist Kristin Neva had been searching awhile for equipment that would help with her husband's ALS management. It took repeated searches.

Riluzole treatment and a diet containing high glycemic index foods interact 'synergistically' to slow ALS progression, ...

David Husman, a Chicago businessman, donated the money to advance an ALS and a neuroscience center where his wife had been ...

Half of ALS patients experience constipation, which is associated with faster progression and lower survival rates, per a ...

Alchemab Therapeutics has partnered with Eli Lilly to develop new antibody treatments for amyotrophic lateral sclerosis (ALS) based on an approach that looks at the immune response of those with ...

ALS patients' disease progression and improved functional independence and mobility in a real-world setting, per a study.